May 16, 2026 Favipiravir vs Ribavirin for Lassa Fever: Phase 2 Trial Highlights Safety and Treatment Potential in Nigeria
May 14, 2026 Abatacept Outperforms Hydroxychloroquine in Preventing Palindromic Rheumatism Progression to Persistent Arthritis